Fate of the junction phosphate in alternating forward and reverse self-splicing reactions of group II intron RNA.
The RNA-catalysed self-splicing reaction of group II intron RNA is assumed to proceed by two consecutive transesterification steps, accompanied by lariat formation. This is effectively analogous to the small nuclear ribonucleoprotein (snRNP)-mediated nuclear pre-mRNA splicing process. Upon excision from pre-RNA, a group II lariat intervening sequence (IVS) has the capacity to re-integrate into its cognate exons, reconstituting the original pre-RNA. The process of reverse self-splicing is presumed to be a true reversion of both transesterification steps used in forward splicing. To investigate the fate of the esterified phosphate groups in splicing we assayed various exon substrates (5'E-*p3'E) containing a unique 32P-labelled phosphodiester at the ligation junction. In combined studies of alternating reverse and forward splicing we have demonstrated that the labelled phosphorus atom is displaced in conjunction with the 3' exon from the ligation junction to the 3' splice site and vice versa. Neither the nature of the 3' exon sequence nor its sequence composition acts as a prominent determinant for both substrate specificity and site-specific transesterification reactions catalysed by bI1 IVS. A cytosine ribonucleotide (pCp; pCOH) or even deoxyoligonucleotides could function as an efficient substitute for the authentic 3' exon in reverse and in forward splicing. Furthermore, the 3' exon can be single monophosphate group. Upon incubation of 3' phosphorylated 5' exon substrate (5'E-*p) with lariat IVS the 3'-terminal phosphate group is transferred in reverse and forward splicing like an authentic 3' exon, but with lower efficiency. In the absence of 3' exon nucleotides, it appears that substrate specificity is provided predominantly by the base-pairing interactions of the intronic exon binding site (EBS) sequences with the intron binding site (IBS) sequences in the 5' exon. These studies substantiate the predicted transesterification pathway in forward and reverse splicing and extend the catalytic repertoire of group II IVS in that they can act as a potential and sequence-specific transferase in vitro.
Müller
M W
MW
Institut für Mikrobiologie und Genetik, Universität Wien, Vienna, Austria.
Stocker
P
P
Hetzer
M
M
Schweyen
R J
RJ
D001483:Base Sequence; D002384:Catalysis; D004247:DNA / Q000737:chemistry; D004952:Esters; D005091:Exons; D007438:Introns; D008969:Molecular Sequence Data; D009694:Nucleic Acid Precursors / Q000378:metabolism*; D010710:Phosphates / Q000737:chemistry*; D012313:RNA / Q000737:chemistry; D012326:RNA Splicing; D013329:Structure-Activity Relationship
D004952:Esters; D009694:Nucleic Acid Precursors; D010710:Phosphates; D012313:RNA; D004247:DNA